[Form 4] Sharps Technology Inc. Warrant Insider Trading Activity

Rhea-AI Filing Summary

The reporting person, Soren Bo Christiansen, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 at an exercise price of $6.41 per share under the company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026. Following the grant the reporting person beneficially owns 80,000 shares/options as reported.

Insights

Corporate Governance Expert

TL;DR: Routine director equity grant aligns incentives but introduces potential dilution when exercised.

The filing documents a standard option award to a director under the 2025 Equity Incentive Plan: 80,000 options at a $6.41 exercise price, fully vesting on May 22, 2026. From a governance perspective, such grants are common for aligning executive and director interests with shareholder outcomes. The delayed vesting indicates a retention objective through mid-2026. Materiality is low absent additional context on company size or total outstanding shares; this appears to be a routine compensation action rather than a transactional disclosure that would by itself materially change investor valuation.

Securities Analyst

TL;DR: Option grant is disclosure-worthy but likely immaterial to STSS valuation unless large relative to outstanding shares.

This Form 4 reports an options grant (08/22/2025) with exercise price $6.41 and full vesting on 05/22/2026. For investors assessing dilution risk, the key inputs missing from this filing are total outstanding shares and total options outstanding under the 2025 plan. Without that context the impact on share count and EPS is unknown. The disclosure does, however, confirm insider alignment through equity compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Christiansen Soren Bo

(Last) (First) (Middle)

C/O SHARPS TECHNOLOGY, INC.

105 MAXESS ROAD, STE. 124

(Street)

MELVILLE NY 11747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Option (right to buy)	08/22/2025		P		80,000	A	$6.41	80,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026.

	/s/ Soren Bo Christiansen	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sharps Technology (STSS) report on this Form 4?

Soren Bo Christiansen, a director, was granted an option to buy 80,000 shares on 08/22/2025 at an exercise price of $6.41, vesting 100% on 05/22/2026.

How many shares does the reporting person beneficially own after the transaction?

The filing reports beneficial ownership of 80,000 shares/options following the reported transaction.

Under what plan were the options granted?

The options were granted pursuant to the company's 2025 Equity Incentive Plan as stated in the filing.

What is the exercise price and when do the options vest?

The exercise price is $6.41 per share and the options become fully exercisable on May 22, 2026.

Does the Form 4 indicate any immediate sale or disposition?

No. The Form 4 shows an acquisition (grant) of options on 08/22/2025, not a disposition.